Dr. Kirsty Lee






Name


Kirsty Wai Chung Lee

Qualifications


MBChB, MRCP (UK),FHKAM (Medicine), FHKCP (Oncology), FRACP (Oncology), PgDip (PalliativeMedicine)

Rank


Clinical Professional Consultant

ORCID No.


0000-0002-6446-6585

Email


kirstylee@clo.cuhk.edu.hk

Specific Research / Sites of Interest


Breast cancer

Lung cancer

Gynaecological malignancies

Hyperthermic intraperitoneal chemotherapy

Supportive care in cancer


Short Biography


Dr. Kirsty Lee graduated from the Chinese University of Hong Kong in 2006 and obtained specialist qualification in medical oncology in 2013. She was awarded a distinction by Cardiff University for diploma certification in palliative medicine in 2016. She obtained fellowship with the Royal Australasian College of Physicians in 2019 after working in St George Hospital, Sydney.
During her medical training in Hong Kong, her research included molecular diagnostics in lung cancer, and supportive care. Her practice and research in Sydney focused on cancers of the lung, breast, gynaecological and gastrointestinal malignancies.
Dr Lee has obtained travel grants from the European Society of Medical oncology (ESMO), and the Australia and Asia Pacific Clinical Oncology Resarch Development Workshop. She has represented and advised the Hong Kong Alliance for Rare Diseases in advocating better services for patients with rare cancers.

Most Representative Publications


Lee KWC, Lord S, Kasherman L,Marschner I, Stockler M, Gralla R, Yang JCH, Mok T, Lee CK. The impact of smoking on the effectiveness of immune checkpoint inhibitors — a systematic review and meta-analysis. Acta Oncol. 2019. 25:1-5.

Lee KWC, Lord S, Finn RS, Lim E, Martin A, Loi S, Lynch J,Friedlander M, Lee CK. The impact of ethnicity on efficacy and toxicity of cyclin D kinase 4/6 inhibitors in advanced breast cancer — a meta-analysis. Breast Cancer Res Treat. 2019. 174(1):271-278

Lee KWC, Chan SL. Hepatotoxicity of targeted therapy for cancer. Expert Opin Drug Metab Toxicol 2016. 12(7): 789-802.

Chan SL, Wong AM, Lee K, Wong N, Chan AKC. Personalized therapy for hepatocellular carcinoma: Where are we now? Cancer Treat Rev 2016. 45:77-86

Mok TSK, Lee K, Leung L. Targeting Epidermal Growth Factor Receptor in the Management of Lung Cancer. Semin Oncol. 2014. 41: 101-109.